| 107P Immune Checkpoint Inhibitor (ICPI) resistance genes STK11 and KEAP1: A comparative Comprehensive Genomic Profiling (CGP) study B Alexander, ES Sokol, NA Danziger, DC Pavlick, J Elvin, JK Killian, ... Annals of Oncology 31, S283-S284, 2020 | | 2020 |
| 130P PTCH1 Genomic Alterations (GA) in human malignancies: A pangenomic study JS Ross, ES Sokol, DC Pavlick, JA Vergilio, JK Killian, E Williams, ... Annals of Oncology 31, S291-S292, 2020 | | 2020 |
| 1455 Characterization of gene expression signatures of tumor immunogenicity and cellular proliferation from murine cancer models grown in vitro and in vivo KC Strickland, S Barnes, ZD Wallen, MK Nesline, TJ Jensen, B Caveney, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 1499 Molecular and immune profiling of lobular-enriched versus non-lobular invasive breast cancers KC Strickland, S Pabla, H Ko, RA Previs, ZD Wallen, MK Nesline, S Zhang, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 1654 Relapsed and Metastatic Hepatoblastoma: A Comprehensive Genomic Profi ling Study S Ainechi, LM Gay, JA Elvin, JA Vergilio, J Suh, SH Ramkissoon, SM Ali, ... | | |
| 173 Sensitivity and concordance of CD274 expression by RNA sequencing (RNA-seq) in comparison with three PD-L1 immunohistochemistry methods in head and neck squamous cell … M Nesline, S Pabla, J Conroy, P DePietro, S Zhang, R Klein, A Bhagelu, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| 175 Metastatic triple negative breast cancer has distinct tumor immune landscape R Seager, H Ko, S Pabla, MF Senosain, E Van Roey, S Gao, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 176 Immune microenvironment of primary versus metastatic melanoma of the brain MF Senosain, H Ko, S Pabla, R Seager, E Van Roey, S Gao, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 1774 Abnormal Hepatocellular Mitochondria in Methylmalonic Acidemia MS Abedalthagafi, SH Ramkissoon, KL Ligon, AH Ligon, RD Folkerth, ... | | |
| 183 Comprehensive genomic and immune profiling (CGIP) reveals a distinct genomic and immune gene expression profile for younger patients with non-small cell lung cancer (NSCLC) ZD Wallen, H Ko, MK Nesline, SB Hastings, KC Strickland, RA Previs, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 184 Distinct immunotherapy immune response phenotypes in non-small cell lung cancer present with unique genomic alteration profiles ZD Wallen, RJ Seager, S Pabla, MK Nesline, E Van Roey, S Gao, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 2001P Adenoid cystic carcinomas (ACC) of the trachea, salivary gland, breast: A comparative comprehensive genomic profiling (CGP) study J Elvin, NA Danziger, J Corines, JA Vergilio, JK Killian, DI Lin, E Williams, ... Annals of Oncology 31, S1117-S1118, 2020 | | 2020 |
| 513 Comprehensive genomic and immune profiling of ALK fusion-positive and negative lung adenocarcinomas KC Strickland, ZD Wallen, S Pabla, H Ko, MK Nesline, RA Previs, S Zhang, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 694P Methylthioadenosine phosphorylase (MTAP) deletion is more common in sarcomatoid (srcRCC) than in clear cell renal cell carcinoma (ccRCC) A Necchi, P Grivas, PE Spiess, J Jacob, E Sokol, S Ramkissoon, ... Annals of Oncology 32, S708-S709, 2021 | 3 | 2021 |
| 787P Urachal (URAC) and non-urachal (NURAC) adenocarcinomas of the urinary bladder: A comparative comprehensive genomic profiling (CGP) study G Bratslavsky, P Grivas, A Necchi, O Shapiro, J Jacob, J Elvin, JA Vergilio, ... Annals of Oncology 31, S600-S601, 2020 | | 2020 |
| 80 Smarca4 inactivation defines a subset of undifferentiated uterine sarcomas with rhabdoid and small cell features and germline mutation association D Lin, J Allen, J Hecht, J Killian, N Ngo, C Edgerly, E Severson, S Ali, ... International Journal of Gynecologic Cancer 29 (Suppl 3), 2019 | | 2019 |
| 846. Characterization of brain tumor mutations from cell-free DNA in cerebrospinal fluid J Coburger, J Engelke, A Scheuerle, D Thal, M Hlavac, T Kretschmer, ... Journal of Neurosurgery 122 (6), A1520-A1579, 2015 | 1 | 2015 |
| 87 Distinctions in Tumor Microenvironment Between PD-L1 Positive versus Negative Head and Neck Squamous Cell Carcinoma (HNSCC) KS Saini, HC Ko, ZD Wallen, MF Green, KC Strickland, RA Previs, ... Radiotherapy and Oncology 192, S20-S22, 2024 | | 2024 |
| 957P Ameloblastoma of the head and neck (HNAMB): A comprehensive profiling (CGP) study P Reddy, NA Danziger, J Elvin, JA Vergilio, JK Killian, DI Lin, E Williams, ... Annals of Oncology 31, S677-S678, 2020 | | 2020 |
| A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomas Y Sun, JA Alberta, C Pilarz, D Calligaris, EJ Chadwick, SH Ramkissoon, ... Neuro-oncology 19 (6), 774-785, 2017 | 94 | 2017 |
